G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription

scientific article

G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1994PNAS...91.3092V
P356DOI10.1073/PNAS.91.8.3092
P8608Fatcat IDrelease_7ayk4r4ix5cvlhwnflsgfhcefi
P932PMC publication ID43521
P698PubMed publication ID7512722
P5875ResearchGate publication ID15685827

P50authorAndreas MeyerhansQ40808712
P2093author name stringSala M
Vartanian JP
Wain-Hobson S
P2860cites workModulation of mutagenesis by deoxyribonucleotide levelsQ28262307
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertionsQ33732677
Rapid evolution of RNA virusesQ34174014
The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cellsQ34498295
Next-nucleotide effects in mutations driven by DNA precursor pool imbalances at the aprt locus of Chinese hamster ovary cellsQ34634648
Human immunodeficiency virus type 1 quasispecies in vivo and ex vivoQ36188852
DNA precursor asymmetries, replication fidelity, and variable genome evolutionQ36350924
Biological asymmetries and the fidelity of eukaryotic DNA replicationQ36350943
Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomesQ36683672
Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitroQ36687926
Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growthQ36688463
The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitroQ36698743
Human infection by genetically diverse SIVSM-related HIV-2 in west AfricaQ39242650
Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools.Q40037984
Reverse transcriptases and genomic variability: the accuracy of DNA replication is enzyme specific and sequence dependentQ41136644
Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virusQ41611077
HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutionsQ43500863
The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaquesQ44357802
Biased hypermutation and other genetic changes in defective measles viruses in human brain infectionsQ45060135
Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutionsQ45796860
RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virusQ45847939
The effects of dNTP pool imbalances on frameshift fidelity during DNA replicationQ46675305
Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA.Q52868697
Fidelity of HIV-1 reverse transcriptaseQ56904813
Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cellsQ68504983
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolationsQ69355758
The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocationQ69990427
P433issue8
P407language of work or nameEnglishQ1860
P304page(s)3092-3096
P577publication date1994-04-01
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleG-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription
P478volume91

Reverse relations

cites work (P2860)
Q304534673'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.
Q37371679A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
Q37140468APOBEC proteins and intrinsic resistance to HIV-1 infection
Q24318854APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G
Q24618320APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis
Q33389841APOBEC3G inhibits elongation of HIV-1 reverse transcripts
Q40899809APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase
Q34211562APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon
Q42945468APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia
Q38394187APOBECs and virus restriction
Q35729054Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.
Q28776128Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis
Q38441445Antigenic stimulation specifically reactivates the replication of archived simian immunodeficiency virus genomes in chronically infected macaques
Q34590679Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules
Q42183255Circulating type 1 vaccine-derived poliovirus may evolve under the pressure of adenosine deaminases acting on RNA.
Q24498729Codon usage limitation in the expression of HIV-1 envelope glycoprotein
Q36747913Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants
Q46200486Compensatory nature of Chargaff's second parity rule
Q41915533Complex codon usage pattern and compositional features of retroviruses.
Q57068874Composition bias and genome polarity of RNA viruses
Q51942900Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV.
Q28179534DNA deamination mediates innate immunity to retroviral infection
Q37333883Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets
Q33784748Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate
Q36969977Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine
Q38362195Efficiency of correct nucleotide insertion governs DNA polymerase fidelity.
Q39603104Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIV.
Q41064129Exploring the functional robustness of an enzyme by in vitro evolution
Q39715283Fate of direct and inverted repeats in the RNA hypermutagenesis reaction
Q47304570HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs
Q40058710HIV-1 tolerates changes in A-count in a small segment of the pol gene
Q33853620Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells
Q41125504Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription
Q40789457Human immunodeficiency virus type 1 reverse transcriptase tG:T mispair formation on RNA and DNA templates with mismatched primers: a kinetic and thermodynamic study.
Q35938679Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations
Q36813813Hypermutagenic PCR involving all four transitions and a sizeable proportion of transversions.
Q92092331Hypermutations in porcine respiratory and reproductive syndrome virus
Q48178264Identification of a preferred region for recombination and mutation in HIV-1 gag.
Q54610160Identification of an essential second metal ion in the reaction mechanism of Escherichia coli adenylosuccinate synthetase.
Q36858891In search of a function for the most frequent naturally-occurring length polymorphism (MFNLP) of the HIV-1 LTR: retaining functional coupling, of Nef and RBF-2, at RBEIII?
Q33279566In silico segmentations of lentivirus envelope sequences.
Q34116867In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients
Q40675013Increased G-->A transition frequencies displayed by primer grip mutants of human immunodeficiency virus type 1 reverse transcriptase
Q46227536Increasing the CpG dinucleotide abundance in the HIV-1 genomic RNA inhibits viral replication.
Q35685039Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives
Q34107265Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms
Q33815187Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
Q24805644Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells
Q36008905Lethal mutagenesis of HIV.
Q35868716Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering
Q37593180Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Q35122784Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription
Q33946094Methods for assessing feline immunodeficiency virus infection, infectivity and purification
Q33958359Modeling and optimization of populations subject to time-dependent mutation
Q38292321Modification of retroviral RNA by double-stranded RNA adenosine deaminase.
Q33782982Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients
Q40714016Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis
Q41350528Natural DNA precursor pool asymmetry and base sequence context as determinants of replication fidelity
Q21144862Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity
Q33671155Naturally occurring variants of hepatitis B virus
Q24498479On the nucleotide composition and structure of retroviral RNA genomes
Q93194984Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies
Q34490344Population dynamics of HIV-1 inferred from gene sequences.
Q33641547Quasispecies theory and the behavior of RNA viruses
Q37568313Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates
Q24630459Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha
Q40394875Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction.
Q53991557Sexual transmission of HIV-1 isolate showing G-->A hypermutation.
Q28187133Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
Q36673297Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid
Q42551705Substitutions in the Reverse Transcriptase and Protease Genes of HIV-1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs
Q46862226Substitutions in the reverse transcriptase and protease genes of HIV-1 subtype B in untreated individuals and patients treated with antiretroviral drugs.
Q35887132Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history
Q24498331The A-nucleotide preference of HIV-1 in the context of its structured RNA genome
Q26862780The APOBEC3 family of retroelement restriction factors
Q37738500The Evolution of LINE-1 in Vertebrates.
Q24498366The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity
Q24305266The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Q83181178The genetic stability of a conditional live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution
Q27469694Unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1
Q21245205Use of endogenous retroviral sequences (ERVs) and structural markers for retroviral phylogenetic inference and taxonomy
Q46057383Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells.

Search more.